Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DHA:JHRML'
s EV-to-EBIT Range Over the Past 10 Years
Min: 4.81 Med: 18.86 Max: 36.81
Current: 24.26
During the past 5 years, the highest EV-to-EBIT of JMI Hospital Requisite Manufacturing was 36.81. The lowest was 4.81. And the median was 18.86.
DHA:JHRML's EV-to-EBIT is ranked worse than 63.64% of 473
companies
in the Medical Devices & Instruments industry
Industry Median: 18.87
vs DHA:JHRML: 24.26
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
JMI Hospital Requisite Manufacturing's Enterprise Value for the quarter that ended in Mar. 2026 was BDT6,616 Mil.
JMI Hospital Requisite Manufacturing's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT315 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMI Hospital Requisite Manufacturing EV-to-EBIT Related Terms
JMI Hospital Requisite Manufacturing EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:JHRML vs ISRG, BDX, MDLN: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, JMI Hospital Requisite Manufacturing's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMI Hospital Requisite Manufacturing EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMI Hospital Requisite Manufacturing's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where JMI Hospital Requisite Manufacturing's EV-to-EBIT falls into.
JMI Hospital Requisite Manufacturing's current Enterprise Value is BDT7,643 Mil.
JMI Hospital Requisite Manufacturing's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT315 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMI Hospital Requisite Manufacturing (DHA:JHRML) has a EV-to-EBIT of 24.26 as of Aug. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on JMI Hospital Requisite Manufacturing and its competitors. This is 29% above median its historical median of 18.86. Over the past decade, JMI Hospital Requisite Manufacturing's EV-to-EBIT has ranged from 4.81 to 36.81. According to the industry distribution chart, JMI Hospital Requisite Manufacturing ranks #301 out of 473 companies in the Medical Devices & Instruments industry, placing it in the top 63.6%.
Is JMI Hospital Requisite Manufacturing's EV-to-EBIT too high?
JMI Hospital Requisite Manufacturing's current EV-to-EBIT of 24.26 is 29% above median its 10-year median of 18.86. Over the past 10 years, this metric has ranged from a low of 4.81 to a high of 36.81. The Medical Devices & Instruments industry median EV-to-EBIT is 18.87. JMI Hospital Requisite Manufacturing's value of 24.26 is 28.6% above this industry median. Based on the distribution chart, JMI Hospital Requisite Manufacturing ranks #301 out of 473 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, JMI Hospital Requisite Manufacturing has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMI Hospital Requisite Manufacturing's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMI Hospital Requisite Manufacturing ranks #301 out of 473 companies for EV-to-EBIT. This places JMI Hospital Requisite Manufacturing in the lower half of its industry. The industry median EV-to-EBIT is 18.87. JMI Hospital Requisite Manufacturing's value of 24.26 is 28.6% above this benchmark. Historically, JMI Hospital Requisite Manufacturing's own EV-to-EBIT has ranged from 4.81 to 36.81 over the past decade. While the company's 10-year median is 18.86 vs. the industry median of 18.87, JMI Hospital Requisite Manufacturing has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.87, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMI Hospital Requisite Manufacturing's current EV-to-EBIT of 24.26 is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on JMI Hospital Requisite Manufacturing and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMI Hospital Requisite Manufacturing's current EV-to-EBIT is 24.26, which is 29% above median its own 10-year median of 18.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Hospital Requisite Manufacturing stock overvalued right now?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing (DHA:JHRML) is currently considered Fairly Valued. The stock's GF Value™ is BDT50.35, compared to a current price of BDT50.90 — trading 1.1% above its estimated fair value. The current EV-to-EBIT is 24.26, which is 29% above median its 10-year median of 18.86 and 28.6% above the Medical Devices & Instruments industry median of 18.87. JMI Hospital Requisite Manufacturing's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For JMI Hospital Requisite Manufacturing (DHA:JHRML), the current EV-to-EBIT is 24.26 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMI Hospital Requisite Manufacturing (DHA:JHRML) Overvalued in 2026?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing stock appears to be overvalued.
The current stock price of BDT50.90 is trading 1.1% above its estimated GF Value™ of BDT50.35.
GuruFocus considers JMI Hospital Requisite Manufacturing to be Fairly Valued.
Key valuation signals for DHA:JHRML:
EV-to-EBIT: 24.26 (29% above median its 10-year median of 18.86)
GF Value™: BDT50.35 vs. price of BDT50.90 (1.1% above fair value)
Industry Position: 28.6% above the Medical Devices & Instruments median (#301 of 473)
No single metric tells the full story. See the DHA:JHRML stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMI Hospital Requisite Manufacturing Ltd is engaged in the production of medical devices and components. The company produces health & hospicare products. The products of the company include Surgical Sutures, Surgical Gloves, IV Cannula, Bulk Needles, Blister Film, Infusion Set Components, Disposable Scalpels, Nasal Oxygen Cannulas, Blood Transfusion Sets, Urine Drainage Bags, Scalp Vein Sets, and others.
68GF Score
Get the complete analysis for DHA:JHRML
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:JHRML has been successfully added to your 
